Expression of Epidermal Growth Factor Receptor in Human Middle Ear Cholesteatoma

The Kaohsiung Journal of Medical Sciences - Tập 19 - Trang 497-501 - 2003
Ying-Che Hsu1, Kuen-Yao Ho1, Ka-Wo Lee1, Ling-Feng Wang1, Wen-Rei Kuo1
1Department of Otolaryngology, Kaohsiung Medical University, Kaohsiung, Taiwan

Tóm tắt

Middle ear cholesteatoma is destructive to auditory ossicles and temporal bone, and treatment usually includes surgical removal of all epithelial content in the tympanomastoid cavity. Epidermal growth factor receptor (EGFR) is a 170 kd to 180 kd transmembrane glycoprotein and its distribution density is related to the ability of the keratinocytes to differentiate and their state of differentiation. We used the avidinbiotin complex technique and EGFR monoclonal antibody to evaluate the expression of EGFR in 29 cases of cholesteatoma and 34 samples of normal postauricular skin. Of patients with cholesteatoma, 79% (23 cases) had EGFR‐positive cells in the basal layer, 66% (19 cases) in the parabasal layer, and 62% (18 cases) in the upper layer of the epithelial tissue. Among patients with normal postauricular skin, 85% (29 cases) had EGFR‐positive cells in the basal layer, 79% (27 cases) in the parabasal layer, and 79% (27 cases) in the upper layer of the epithelial tissue. No statistical difference in EGFR expression between each layer of cholesteatoma and postauricular skin was noted. However, there was an intensity gradient of positive EGFR immunoreactivity from the basal to the higher layers in cholesteatoma. Our results showed that the distribution of EGFR in middle ear cholesteatoma is not deranged, but is similar to that in normal skin tissue.

Tài liệu tham khảo

10.3109/00016488109138508 10.1038/311414a0 10.1016/0014-4827(85)90098-9 10.1007/BF00426583 Ergun S, 1996, Expression of transforming growth factor‐alpha and epidermal growth factor receptor in middle ear cholesteatoma, Am J Otol, 17, 393 10.1016/0196-0709(93)90044-8 10.1111/1523-1747.ep12264708 10.1111/j.1600-0560.1992.tb01561.x Uno Y, 1994, Localization of epidermal growth factor receptor (EGFR) in human cholesteatoma — immunohistochemical studies, Otol Jpn, 4, 78 10.1288/00005537-199303000-00015 Bujia J, 1996, Epidermal growth factor receptor (EGF‐R) in human middle ear cholesteatoma: an analysis of protein production and gene expression, Am J Otol, 17, 203 10.1111/1523-1747.ep12259731 10.1001/archotol.124.3.261 10.1007/s004050100315 10.1080/00016489950181756 Rodeck U, 1997, EGF‐R dependent regulation of keratinocyte survival, J Cell Sci, 110, 113, 10.1242/jcs.110.2.113 10.3109/00016489409126081 Shieh TJ, 1999, Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen, Kaohsiung J Med Sci, 15, 468 10.1016/S0194-5998(96)70287-5 Albino AP, 1998, Cholesteatoma: a molecular and cellular puzzle, Am J Otol, 19, 7